Clinical Trials Logo

Filter by:
NCT ID: NCT01505816 Completed - Cataract Clinical Trials

Visual Outcomes After Implantation of a New Multifocal Intraocular Lens

Start date: October 2011
Phase: Phase 4
Study type: Interventional

This prospective nonrandomized study comprised patients with cataract, corneal astigmatism, and motivation for spectacle independence. In all cases, a Rayner M-flex® T toric Intraocular Lens will be implanted in the capsular bag. Three months postoperatively, distance, intermediate, and near visual acuities; spherical equivalent; residual refractive astigmatism; defocus curve; and contrast sensitivity will be evaluated. A patient-satisfaction and visual phenomena questionnaire will also be administered.

NCT ID: NCT01504841 Completed - HIV Infections Clinical Trials

Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children

Start date: March 14, 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are widely used as part of combination antiretroviral therapy (ART) for infants and children, but NNRTI resistance is increasing, leading to treatment failure. This study tested the safety, tolerability, and dosing levels of etravirine (ETR), a new NNRTI.

NCT ID: NCT01502566 Completed - Dental Caries Clinical Trials

Educational Intervention in Preventing Early Childhood Caries

Start date: June 2010
Phase: Phase 3
Study type: Interventional

Objective: The aim of this study is to assess the effectiveness of an oral health educative intervention in preventing early childhood caries (ECC). Methods: The trial targets 0- to 12-month-old children and their mothers in Pelotas, Brazil. Twenty-four public health centres (clusters) were randomly selected and assigned to intervention or control group (12 clusters per intervention group). In each center, up to 30 children/mothers were selected and invited to participate in the trial. Each mother was interviewed in order to collect socio-economic and demographic variables. The intervention group received by means of a pamphlet the oral health instructions, which were emphasized with verbal instructions. Dental examination will be carried out after 1 year for all teeth surfaces to determine caries status.

NCT ID: NCT01502215 Completed - Clinical trials for Red Blood Cells Transfusion

Transfusion Requirements in Surgical Oncologic Patient

TRISOP
Start date: January 2012
Phase: Phase 3
Study type: Interventional

Blood transfusion during perioperative period in patients undergoing to major surgery has been associated to several postoperative complications. Particularly in oncologic surgery, red blood cell transfusion has been investigated as a factor of worse outcome and cancer recurrence due to postoperative impairment of cellular immunity. Although red blood cell transfusion has decreased in worldwide clinical practice, this issue still remains a matter of controversy in oncologic surgery. There are no prospective studies comparing outcomes between restrictive or liberal of blood transfusion strategy in oncologic surgery. This study is a prospective and randomized study comparing clinical outcomes between two strategies of transfusion in oncologic surgery - liberal or restrictive

NCT ID: NCT01502059 Completed - Pain Clinical Trials

Pilates to Treat Low Back Pain

PTLBP
Start date: June 2008
Phase: Phase 3
Study type: Interventional

This is a randomized controlled trial, with blinded assessor to evaluate the effectiveness of Pilates to treat low back pain. Hypothesis - the Pilates group will have best results than the control group (usual medicament treatment).

NCT ID: NCT01501357 Completed - Caries Clinical Trials

Effectiveness of Toothbrushing Techniques in Plaque Removal and Caries Lesion Control

toothbrushing
Start date: July 2011
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate the effectiveness of cross-toothbrushing technique compared with anteroposterior and biofilm removal and control of caries lesions in first permanent molars.

NCT ID: NCT01501110 Completed - Clinical trials for Acute Myocardial Infarction

Effects of N-acetylcysteine on Low T3 Syndrome

Start date: November 2011
Phase: Phase 4
Study type: Interventional

The propose of this study is to determine whether N-acetylcysteine is effective in reversing the changes in thyroid hormones seen in critical illness, known as the low T3 syndrome.

NCT ID: NCT01500720 Completed - Clinical trials for Small Cell Lung Cancer

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Start date: March 2012
Phase: Phase 2
Study type: Interventional

Primary Objective: To demonstrate progression free survival (PFS) improvement for cabazitaxel compared to topotecan in participants with sensitive or resistant/refractory small cell lung cancer following a first line platinum based chemotherapy. Secondary Objectives: - To assess disease progression free rate at 12 weeks - To assess Response Rate (Response Evaluation Criteria in Solid Tumor [RECIST] 1.1) and duration of response - To assess Overall Survival (OS) - To assess the Safety (National Cancer Institute - Common Toxicity Criteria [NCI-CTC] version 4.03) - To assess the Health-Related Quality of Life (HRQoL)

NCT ID: NCT01500343 Completed - Heart Failure Clinical Trials

A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients. Estudo PROICA

PROICA
Start date: November 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the feasibility, safety and effects in inflammatory response of the therapy with a probiotic agent, the yeast Saccharomyces boulardii (SB), in chronic heart failure patients.

NCT ID: NCT01500239 Completed - Clinical trials for Complicated Intra-Abdominal Infection

A Study Comparing Ceftazidime-Avibactam+Metronidazole Versus Meropenem in Adults With Complicated Intra-abdominal Infections

Start date: April 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effects of Ceftazidime Avibactam plus Metronidazole compared to Meropenem for treating hospitalized patients with complicated intra-abdominal infections.